<p>Dr. Peluso is an infectious disease physician at the University of California, San Francisco. Prior to COVID, his research focus was on the chronic sequelae of HIV infection. When the SARS-CoV-2 pandemic emerged, Dr. Peluso led the efforts to implement the Long-term Impact of Infection with Novel Coronavirus (LIINC, pronounced “link”) study at San Francisco General Hospital, based on the hypothesis that COVID could have a long-term impact on health and well-being. LIINC was one of the first post-COVID cohorts in the U.S. and now includes hundreds of individuals with and without Long COVID, many of whom have been followed for more than 2 years. He leads projects within LIINC aimed at understanding the biological mechanisms that drive Long COVID and is also responsible for implementation of the UCSF enrolling sites for the NIH’s RECOVER initiative.</p>
